NEW YORK (GenomeWeb News) — Case Western Reserve University has received a grant worth up to $3 million from the National Institute of Drug Abuse to conduct proteomic studies of Hepatitis C and HIV infections, Case's School of Medicine said today.

The three-year NIDA grant will fund development of proteomic and epigenetic markers for chronic immune activation during HIV disease and studies of the effects of current and prior drug use and HCV infection on disease progression and therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.